Skip to main content
search

Regulatory

Sign up

Latest resources

Featured resource

Upcoming regulatory webinars

Latest regulatory blogs

Meet our experts at the following events

Conference

ISSX 2025 International Meeting

September 12 - 14, 2025 – Chicago, Illinois
Conference

SCDM 2025 Annual Conference

September 27 - 30, 2025
Conference

ACoP 2025

October 18 - 21, 2025

All regulatory resources

Building PK/PD Workflows with Cloud and AI – APAC Webinar

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Webinar

SDTM Specification Management

Certara Products - Pinnacle 21, Fact Sheet

MIDD can ease pediatric & rare disease drug loss in Japan

Certara Services, Clinical Pharmacology, Model Informed Drug Development, Modeling and Simulation, Pediatrics, Blog

Pirana Tips and Tricks – Report Object Generation in Pirana

Certara Products, Webinar

SCDM 2025 Annual Conference

Certara Products - Pinnacle 21, Conference

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

Certara Products, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Blog

The Do’s and Don’ts of Define.xml

CDISC, Certara Products - Pinnacle 21, Define-XML, Blog

How Model-informed drug development rescue projects from a risky situation​

Certara Services, Clinical Pharmacology, Homepage Latest, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Case Study

Increasing Productivity In Pharma R&D Starts With Data

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Homepage Latest, Press Coverage

FDA ESG NextGen for Regulatory Submissions

Certara Products - GlobalSubmit, Blog

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Certara Services, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Publication

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Webinar
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.